No Diet, Nutrition, Chemoprevention Concepts Due For DRCCA Board In October, But Maybe In January
In Brief: Mauer to Leave St. Jude For U. Tennessee As Cancer Program Director; Harvard, MIT Share ACS Award
Prospects Fading for Funding More CCOPsIn FY ’83; Return to Groups Of Money From Satellites Going To New Programs
NCI Developing Policy On Relations Between Industry, DCT Clinical Trials
Firm Reports Limited Market For Self-Test Detection Methods
NCI Advisory Group, Other Cancer Meetings
Trending Stories
- Columbia’s cancer center becomes collateral damage in Trump’s war on antisemitism
- Caught in the crossfire: The critical threats facing cancer centers, research, and patient care
- Kennedy announces massive cuts, centralization at HHS—NCI and FDA hit
Also this week: Columbia yields, Makary and Bhattacharya confirmed, tariffs on pharmaceuticals, and more changes impacting oncology - Pediatric cancer research cut from spending legislation at last minute
Republicans quietly removed hard-won pediatric cancer bills - What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - FDA grants Cytotron Breakthrough Device Designation for breast, liver and pancreatic cancers